CAR-associated hemophagocytic lymphohistiocytosis (HLH) with use of commercial tisagenlecleucel in the Pediatric Real World Car Consortium (PRWCC): Risk factors and outcomes Meeting Abstract


Authors: McNerney, K. O.; Lim, S. S.; Dreyzin, A.; Vatsayan, A.; Baggott, C.; Prabhu, S.; Pacenta, H. L.; Phillips, C. L.; Rossoff, J.; Stefanski, H. E.; Talano, J. A.; Moskop, A.; Margossian, S.; Verneris, M. R.; Myers, D.; Karras, N.; Brown, P. A.; Qayed, M.; Hermiston, M.; Satwani, P.; Krupski, M. C.; Keating, A. K.; Wilcox, R.; Rabik, C. A.; Baumeister, S.; Fabrizio, V. A.; Chinnabhandar, V.; Goksenin, Y.; Curran, K. J.; Mackall, C.; Laetsch, T. W.; Schultz, L. M.
Abstract Title: CAR-associated hemophagocytic lymphohistiocytosis (HLH) with use of commercial tisagenlecleucel in the Pediatric Real World Car Consortium (PRWCC): Risk factors and outcomes
Meeting Title: 2022 Tandem Meetings of ASTCT and CIBMTR
Journal Title: Transplantation and Cellular Therapy
Volume: 28
Issue: 3 Suppl.
Meeting Dates: 2022 Apr 23-26
Meeting Location: Salt Lake City, UT
ISSN: 2666-6367
Publisher: Elsevier Inc.  
Date Published: 2022-03-01
Start Page: S473
End Page: S474
Language: English
DOI: 10.1016/S2666-6367(22)00781-3
PROVIDER: manual
Notes: Meeting Abstract: LBA1 -- Located within the section named "Late Breaking Abstracts"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Joseph Curran
    143 Curran
Related MSK Work